To clarify the role of IL–20 in the pathogenesis of prostate cancer, we first examined whether IL–20 and its receptors (IL-20R1, IL-20R2, and IL-22R1) were expressed in prostate cancer cell lines. Here, IL20 is linked to prostate carcinoma.